Q3 2010

Filed Nov 9, 2010 · 10-Q · 40 days after period end · 0001157523-10-006763

Q3 2010 · 10-Q

Revenue

$13.87M

no prior Q3 2009 on file

Net Income

$1.18M

no prior Q3 2009 on file

EPS Diluted

$0.09

no prior Q3 2009 on file

Operating Income$2,077,637—

Operating Cash Flow

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 9, 2010 · 40 d after period end

Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR